Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase

BACKGROUND: Potentiation of anticancer activity of capecitabine is required to improve its therapeutic index. In colorectal cancer (CRC) cells, we evaluated whether the histone deacetylase-inhibitor vorinostat may induce synergistic antitumour effects in combination with capecitabine by modulating t...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Gennaro, E, Piro, G, Chianese, M I, Franco, R, Cintio, A Di, Moccia, T, Luciano, A, de Ruggiero, I, Bruzzese, F, Avallone, A, Arra, C, Budillon, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994231/
https://www.ncbi.nlm.nih.gov/pubmed/21045833
http://dx.doi.org/10.1038/sj.bjc.6605969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994231/
https://www.ncbi.nlm.nih.gov/pubmed/21045833
http://dx.doi.org/10.1038/sj.bjc.6605969

Ejemplares similares